🇺🇸 FDA
Pipeline program

Matching Placebo tablets without active substance, BIIB122

283PD201

Phase 2 small_molecule active

Quick answer

Matching Placebo tablets without active substance, BIIB122 for Parkinson's Disease is a Phase 2 program (small_molecule) at Biogen Idec Ltd with 1 ClinicalTrials.gov record(s).

Program details

Company
Biogen Idec Ltd
Indication
Parkinson's Disease
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials